![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/19 | |
A61K 38/12 |
(11) | Number of the document | 3054924 |
(13) | Kind of document | T |
(96) | European patent application number | 14780863.8 |
Date of filing the European patent application | 2014-10-06 | |
(97) | Date of publication of the European application | 2016-08-17 |
(45) | Date of publication and mention of the grant of the patent | 2020-11-25 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2014/071302 |
Date | 2014-10-06 |
(87) | Number | WO 2015/052115 |
Date | 2015-04-16 |
(30) | Number | Date | Country code |
13187612 | 2013-10-07 | EP | |
14155993 | 2014-02-20 | EP | |
14162110 | 2014-03-27 | EP |
(72) |
CUBEL SUŃÉ, N ria, ES
|
(73) |
Centrient Pharmaceuticals Netherlands B.V.,
Alexander Fleminglaan 1, 2613 AX Delft,
NL
Galenicum Health S.L.U., Avinguda de Cornellą 144, 7th floor, 08950 Esplugues de Llobregat, ES |
(54) | STABLE PHARMACEUTICAL FORMULATIONS OF CASPOFUNGIN |
STABLE PHARMACEUTICAL FORMULATIONS OF CASPOFUNGIN |